These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 8055787

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Therapy of acromegaly using bromocriptine].
    Köbberling J, Schwinn G, Dirks H.
    Dtsch Med Wochenschr; 1975 Jul 18; 100(29):1540-2. PubMed ID: 1149634
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A.
    Acta Endocrinol Suppl (Copenh); 1978 Jul 18; 216():217-24. PubMed ID: 274038
    [Abstract] [Full Text] [Related]

  • 48. Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind study.
    Schulz A, Lancranjan I, Schürmeyer T, Schuppert F, Hesch RD, von zur Mühlen A, Brabant G.
    J Endocrinol Invest; 1991 Jun 18; 14(6):469-74. PubMed ID: 1774443
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Treatment of acromegaly with bromocriptine (Parlodel)].
    Eskildsen PC.
    Ugeskr Laeger; 1978 May 29; 140(22):1296. PubMed ID: 653875
    [No Abstract] [Full Text] [Related]

  • 52. [125I]hGH metabolism in acromegaly: effects of chronic treatment with 2-Br-alpha-ergocryptine.
    Maneschi F, Navalesi R, Pilo A, Paci A.
    J Clin Endocrinol Metab; 1978 Jul 29; 47(1):110-8. PubMed ID: 263286
    [Abstract] [Full Text] [Related]

  • 53. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
    Jenkins PJ, Jain A, Jones SL, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 1996 Oct 29; 45(4):447-51. PubMed ID: 8959084
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pituitary apoplexy in acromegaly during bromocriptine therapy.
    Yamaji T, Ishibashi M, Kosaka K, Fukushima T, Hori T, Manaka S, Sano K.
    Acta Endocrinol (Copenh); 1981 Oct 29; 98(2):171-7. PubMed ID: 7293648
    [Abstract] [Full Text] [Related]

  • 56. Prevention of puerperal lactation with Parlodel long-acting (Parlodel LA).
    Rolland R, Nijdam W, Weyer A, Lancranjan I.
    Eur J Obstet Gynecol Reprod Biol; 1986 Sep 29; 22(5-6):337-43. PubMed ID: 3770284
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Gastrointestinal bleeding in patients on bromocriptine.
    Wass JA, Thorner MO, Besser GM, Morris D, Mason AS, Liuzzi A, Chiodini PG.
    Lancet; 1976 Oct 16; 2(7990):851. PubMed ID: 61520
    [No Abstract] [Full Text] [Related]

  • 59. Hypotension and bromocriptine.
    O'Mullane NM, Davis JC, Hipkin LJ, Walker BA.
    Lancet; 1976 Dec 18; 2(7999):1358. PubMed ID: 63831
    [No Abstract] [Full Text] [Related]

  • 60. Bromocriptine-induced psychosis in acromegaly.
    Le Feuvre CM, Isaacs AJ, Frank OS.
    Br Med J (Clin Res Ed); 1982 Nov 06; 285(6351):1315. PubMed ID: 6812691
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.